<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Br J Pharmacol</journal-id>
<journal-id journal-id-type="iso-abbrev">Br. J. Pharmacol</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1476-5381</journal-id>
<journal-id journal-id-type="publisher-id">BPH</journal-id>
<journal-title-group>
<journal-title>British Journal of Pharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0007-1188</issn>
<issn pub-type="epub">1476-5381</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29968249</article-id>
<article-id pub-id-type="pmc">6109221</article-id>
<article-id pub-id-type="doi">10.1111/bph.14435</article-id>
<article-id pub-id-type="publisher-id">BPH14435</article-id>
<article-id pub-id-type="other">2018-BJP-0526-RP.R1</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Research Paper</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Research Papers</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Sex‐specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling</article-title>
<alt-title alt-title-type="right-running-head">Sex‐specific valproate‐induced autism and anandamide</alt-title>
<alt-title alt-title-type="left-running-head">F Melancia et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="bph14435-cr-0001">
<name>
<surname>Melancia</surname>
<given-names>Francesca</given-names>
</name>
<xref ref-type="aff" rid="bph14435-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="bph14435-note-0001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph14435-cr-0002">
<name>
<surname>Schiavi</surname>
<given-names>Sara</given-names>
</name>
<xref ref-type="aff" rid="bph14435-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="bph14435-note-0001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph14435-cr-0003">
<name>
<surname>Servadio</surname>
<given-names>Michela</given-names>
</name>
<xref ref-type="aff" rid="bph14435-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph14435-cr-0004">
<name>
<surname>Cartocci</surname>
<given-names>Veronica</given-names>
</name>
<xref ref-type="aff" rid="bph14435-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph14435-cr-0005">
<name>
<surname>Campolongo</surname>
<given-names>Patrizia</given-names>
</name>
<xref ref-type="aff" rid="bph14435-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph14435-cr-0006">
<name>
<surname>Palmery</surname>
<given-names>Maura</given-names>
</name>
<xref ref-type="aff" rid="bph14435-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph14435-cr-0007">
<name>
<surname>Pallottini</surname>
<given-names>Valentina</given-names>
</name>
<xref ref-type="aff" rid="bph14435-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="bph14435-cr-0008">
<name>
<surname>Trezza</surname>
<given-names>Viviana</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3922-6045</contrib-id>
<address>
<email>viviana.trezza@uniroma3.it</email>
</address>
<xref ref-type="aff" rid="bph14435-aff-0001">
<sup>1</sup>
</xref>
</contrib>
</contrib-group>
<aff id="bph14435-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Science, Section of Biomedical Sciences and Technologies</named-content>
<institution>University ‘Roma Tre’</institution>
<named-content content-type="city">Rome</named-content>
<country country="IT">Italy</country>
</aff>
<aff id="bph14435-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Physiology and Pharmacology ‘V. Erspamer’</named-content>
<institution>Sapienza University of Rome</institution>
<named-content content-type="city">Rome</named-content>
<country country="IT">Italy</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold> Viviana Trezza, PhD, Department of Science, Section of Biomedical Sciences and Technologies, University ‘Roma Tre’, Viale G. Marconi 446, Rome 00146, Italy. E‐mail: <email>viviana.trezza@uniroma3.it</email></corresp>
<fn id="bph14435-note-0001">
<label>†</label>
<p>Francesca Melancia and Sara Schiavi made equal contributions to this study.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>9</month>
<year>2018</year>
</pub-date>
<volume>175</volume>
<issue>18</issue>
<issue-id pub-id-type="doi">10.1111/bph.v175.18</issue-id>
<fpage>3699</fpage>
<lpage>3712</lpage>
<history>
<date date-type="received">
<day>27</day>
<month>4</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>05</day>
<month>6</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>6</month>
<year>2018</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2018 The British Pharmacological Society <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2018 The British Pharmacological Society</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:href="file:BPH-175-3699.pdf" xlink:type="simple"></self-uri>
<abstract>
<sec id="bph14435-sec-0001">
<title>Background and Purpose</title>
<p>Autism spectrum disorder (ASD) is more commonly diagnosed in males than in females. Prenatal exposure to the antiepileptic drug valproic acid (VPA) is an environmental risk factor of ASD. Male rats prenatally exposed to VPA show socio‐emotional autistic‐like dysfunctions that have been related to changes in the activity of the endocannabinoid anandamide. Here, we have investigated if prenatal VPA induced sex‐specific autistic endophenotypes involving anandamide signalling.</p>
</sec>
<sec id="bph14435-sec-0002">
<title>Experimental Approach</title>
<p>We studied sex‐specific differences in the ASD‐like socio‐emotional, cognitive and repetitive symptoms displayed during development of Wistar rats of both sexes, prenatally exposed to VPA. The involvement of anandamide was followed by Western blotting of cannabinoid CB<sub>1</sub> receptors and by inhibiting its metabolism.</p>
</sec>
<sec id="bph14435-sec-0003">
<title>Key Results</title>
<p>Female rats were less vulnerable to the deleterious effects of prenatal VPA exposure on social communication, emotional reactivity and cognitive performance than male rats. Conversely, as observed in male rats, prenatal VPA exposure induced selective deficits in social play behaviour and stereotypies in the female rat offspring. At the neurochemical level, prenatal VPA exposure altered phosphorylation of CB<sub>1</sub> receptors in a sex‐specific, age‐specific and tissue‐specific manner. Enhancing anandamide signalling through inhibition of its degradation reversed the behavioural deficits displayed by VPA‐exposed animals of both sexes.</p>
</sec>
<sec id="bph14435-sec-0004">
<title>Conclusions and Implications</title>
<p>These findings highlight sexually dimorphic consequences of prenatal VPA exposure that may be related to sex‐specific effects of VPA on endocannabinoid neurotransmission in the course of development and introduce a new therapeutic target for reversing autistic‐like symptoms in both sexes.</p>
</sec>
</abstract>
<funding-group>
<award-group>
<funding-source>Jerome Lejeune Foundation</funding-source>
<award-id>1674</award-id>
</award-group>
<award-group>
<funding-source>Marie Curie Career Reintegration Grant</funding-source>
<award-id>PCIG09‐GA‐2011‐293589</award-id>
</award-group>
<award-group>
<funding-source>MIUR‐Italy Dipartimenti di eccellenza</funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="6"></fig-count>
<table-count count="0"></table-count>
<page-count count="14"></page-count>
<word-count count="7268"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>bph14435</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>September 2018</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.4.4 mode:remove_FC converted:25.08.2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="bph14435-cit-0000" publication-type="journal">
<string-name>
<surname>Melancia</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Schiavi</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Servadio</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Cartocci</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Campolongo</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Palmery</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Pallottini</surname>, <given-names>V.</given-names>
</string-name>, and <string-name>
<surname>Trezza</surname>, <given-names>V.</given-names>
</string-name> (<year>2018</year>) <article-title>Sex‐specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling</article-title>. <source xml:lang="en"/>British Journal of Pharmacology, <volume>175</volume>: <fpage>3699</fpage>–<lpage>3712</lpage>. <pub-id pub-id-type="doi">10.1111/bph.14435</pub-id>.</mixed-citation>
</p>
</notes>
</front>
</article>
</pmc-articleset>